Arcus Biosciences, Inc. · NYSE:RCUS
Point72 Asset Management, L.P.'s stake in Arcus Biosciences, Inc. fell to 4.10% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Point72 Asset Management, L.P.'s stake in Arcus Biosciences, Inc. fell to 4.10%, 4,332,479 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 4.10%
- Shares
- 4,332,479
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 4.10% | 4,332,479 |
| Point72 Capital Advisors, Inc. | 4.10% | 4,332,479 |
| Steven A. Cohen | 4.10% | 4,332,479 |
Source
Related
- Arcus Biosciences, Inc.
- Point72 Asset Management, L.P.
- Arcus Biosciences, Inc. shareholders
- Schedule 13G · Point72 Asset Management, L.P. · May 13, 2025
- Form 4 · Azoy Alexander · Aug 24, 2026
- Schedule 13D/A · Gilead Sciences, Inc. · Aug 7, 2026
- Form 4 · Jaen Juan C. · Jul 13, 2026
- Form 4 · Jaen Juan C. · Jun 24, 2026
- Form 4 · Lambert Nicole · Jun 12, 2026